Update on therapeutic sector financing by Tim Newton
MDC Senior Market Analyst, Dr Tim Newton provides an update on the therapeutic sector financing. If you attended our ‘UK Life Sciences’ webinar as part of the MDC Connects series, you will have heard Tim’s presentation on decoding therapeutic financing, now at the end of 2024, Tim is back with an update.
Mass Spectrometry Imaging at MDC
In this video, Lead Scientist Dr Philippa Hart speaks about the Mass Spectrometry Imaging capabilities at Medicines Discovery Catapult. Senior Scientist Dr Irma Berrueta Razo provides an overview of the application of mass spectrometry imaging for drug discovery, with a case study to do with Motor Neurone Disease.
MDC Connects 2024 5 of 5 Commercialising your Innovation
Commercialising your Innovation. The final webinar is about commercialising your innovation. Looking at options for commercialisation, in-licencing what does pharma look for? And a case study for successful commercialisation.
MDC Connects 2024 4 of 5 Protecting Intellectual Property
Protecting intellectual property is the title of week four. Identify the novelty, defining IP strategy in a TTO and securing IP.
MDC Connects 2024 3 of 5 Building the Science
Each year, Medicines Discovery Catapult (MDC) aims to connect the community by running a short series of weekly webinars: “MDC Connects”. We invite experts from the community and within MDC to deliver the sessions. Our goal is to educate, inform, and advise the community on the discovery of medicines. 2024 was an informative series outlining […]
MDC Connects 2024 2 of 5 Securing Funds
2 Securing Funds | Tuesday 20 February
Week two was a talk on securing funding. Here, we covered public funding, private funding and the importance of being ‘pitch-ready’.
MDC Connects 2024 1 of 5 UK Life Sciences – the Future is Bright
Webinar one UK Life Sciences – the Future is Bright; creating a richer national R&D pipeline, the current climate and tackling the challenges together.
Narration of the State of the Discovery Nation 2021 Report
A new wave of medicines has emerged in recent years, to supplement the established small and large molecule platforms. These complex medicines will become as important as traditional small molecule drugs in the coming years, with market values of hundreds of billions of pounds. Hear from our CSO, Prof. Peter Simpson as he talks about […]
Webinar – Complex Medicines: Ready for the Clinic/Scaling up for Success
The medicines industry is in a period of change. While small molecule therapeutics still make up 90% of approved medicines, patient expectations are driving the industry towards targeted, precision treatments, which require a shift towards stratified, complex medicines with more challenging discovery and development needs. MDC Connects 2021: A Guide to Complex Medicines is a […]